| Literature DB >> 31379900 |
Robert A Amos1,2, Debra Mohnen1,2.
Abstract
The life cycle and development of plants requires the biosynthesis, deposition, and degradation of cell wall matrix polysaccharides. The structures of the diverse cell wall matrix polysaccharides influence commercially important properties of plant cells, including growth, biomass recalcitrance, organ abscission, and the shelf life of fruits. This review is a comprehensive summary of the matrix polysaccharide glycosyltransferase (GT) activities that have been verified using in vitro assays following heterologous GT protein expression. Plant cell wall (PCW) biosynthetic GTs are primarily integral transmembrane proteins localized to the endoplasmic reticulum and Golgi of the plant secretory system. The low abundance of these enzymes in plant tissues makes them particularly difficult to purify from native plant membranes in quantities sufficient for enzymatic characterization, which is essential to study the functions of the different GTs. Numerous activities in the synthesis of the major cell wall matrix glycans, including pectins, xylans, xyloglucan, mannans, mixed-linkage glucans (MLGs), and arabinogalactan components of AGP proteoglycans have been mapped to specific genes and multi-gene families. Cell wall GTs include those that synthesize the polymer backbones, those that elongate side branches with extended glycosyl chains, and those that add single monosaccharide linkages onto polysaccharide backbones and/or side branches. Three main strategies have been used to identify genes encoding GTs that synthesize cell wall linkages: analysis of membrane fractions enriched for cell wall biosynthetic activities, mutational genetics approaches investigating cell wall compositional phenotypes, and omics-directed identification of putative GTs from sequenced plant genomes. Here we compare the heterologous expression systems used to produce, purify, and study the enzyme activities of PCW GTs, with an emphasis on the eukaryotic systems Nicotiana benthamiana, Pichia pastoris, and human embryonic kidney (HEK293) cells. We discuss the enzymatic properties of GTs including kinetic rates, the chain lengths of polysaccharide products, acceptor oligosaccharide preferences, elongation mechanisms for the synthesis of long-chain polymers, and the formation of GT complexes. Future directions in the study of matrix polysaccharide biosynthesis are proposed.Entities:
Keywords: enzyme mechanism; glycosyltransferase; heterologous expression; matrix glycan; plant cell wall; polysaccharide biosynthesis; protein complex
Year: 2019 PMID: 31379900 PMCID: PMC6646851 DOI: 10.3389/fpls.2019.00915
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Methods for identifying CWGTs for in vitro activity verification. The activities of plant cell wall glycosyltransferases have been identified using three main strategies as outlined in this review: activity enrichment, mutational genetics, and omics-directed GT selection. Heterologous expression and in vitro assays are critical steps in the process of verifying the synthesis of specific cell wall linkages associated with different families of CWGTs. Purification of enzymes following heterologous expressional enables advanced studies of GT mechanism, including enzyme kinetic, and polysaccharide chain length analyses.
Xyloglucan biosynthetic GTs of known function determined by heterologous expression.
| CSLC | D-Glc | β-1,4-Glc | 2 | Unknown: endogenous acceptors or | Unknown elongation size: limited solubility of β-glucan oligosaccharides with chain lengths larger than DP 6. High MW polymerization unknown. | Five-member family. Activity for CSLC4 only. | Cocuron et al., |
| XXT | D-Xyl | α-1,6-Xyl side chain initiation on XG backbone | 34 | XG backbone oligosaccharides, DP 4–6. DP 3 acceptor tested, no activity detected. | Single addition to GGGGGG synthesizes GGXGGG. Less efficient second product, GGXXGG. DP ≥ 4 acceptor required for activity. DP 6 acceptor preferred to DP 5. | Five-member family. Activity for XXT1, 2, 4, and 5. | Faik et al., |
| MUR3 | D-Gal | β-1,2-Gal addition to X side chain (Xyl residue transferred by XXT) | 47 | XG oligosaccharides extracted from | Single addition to XXXG synthesizes XXLG. | One homolog: XLT2. Activity predicted from mutant phenotype. | Madson et al., |
| FUT1 | L-Fuc | α-1,2-Fuc addition to L side chain (Gal residue transferred by MUR3) | 37 | XG oligosaccharides with acceptor sites for Fuc transfer, DP 4: XXLG or XLLG. | Single addition to XXLG synthesizes XXFG. Single addition to XLLG synthesizes XLFG. | 10-member FUT family. XG-related activity for FUT1 only. FUT4 and FUT6 transfer Fuc to AGP side chains. | Perrin et al., |
Abbreviated gene annotations are used (e.g., CSLC rather than “Cellulose synthase-like C”). Additional annotations found in the literature are listed in italics below the gene name. Standard abbreviations for monosaccharides are used. All acceptors are standardized to degree of polymerization (DP) for chain length formatting (e.g., xylohexaose (Xyl.
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of XG backbone synthesis is xyloglucan:β-1,4-glucosyltransferase (XG:β-1,4-GlcT) and the full linkage synthesized is Glcβ-1,4-Glc.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Heteromannan biosynthetic GTs of known function determined by heterologous expression.
| CSLA | D-Man | β-1,4-Man and β-1,4-Glc linkages | 2 | Unknown: endogenous acceptors or | Synthesizes β-1,4-linked polymers containing Glc, Man, or GlcMan depending on substrate availability. High MW products (>100 kDa) detected by size exclusion. | Nine-member family. Activity for CSLA2, 7, and 9. Mutational evidence for CSLA3 activity. | Dhugga et al., |
| CSLD | D-Man | β-1,4-Man | 2 | Unknown: endogenous acceptors or | Unknown elongation size. High MW polymerization unknown. | Six-member family. Activity for CSLD5 and co-expressed CSLD2:CSLD3, but not CSLD2 or CSLD3 individually. | Verhertbruggen et al., |
| GalT | D-Gal | α-1,6-Gal side chain initiation on mannan backbone | 34 | β-1,4-Man mannan backbone oligosaccharides DP 5–10. DP 1–4 acceptors tested, no activity detected. | Single addition to mannan backbone. Unknown regiospecificity of addition. Addition to glucomannan backbone not confirmed | Fenugreek enzyme. Putative Arabidopsis homolog MUCI10. | Edwards et al., |
Gene annotations, abbreviations, and references are formatted as in .
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of mannan backbone synthesis is mannan:β-1,4-mannosyltransferase (mannan:β-1,4-ManT) and the full linkage synthesized is Manβ-1,4-Man.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Xylan biosynthetic GTs of known function determined by heterologous expression.
| XYS1 | D-Xyl | β-1,4-Xyl | 47 | Xylan backbone oligosaccharides, DP 2–6. Xyl monosaccharide tested, no activity detected. | Elongation of DP 6 acceptor up to DP ~21 detected by MALDI. High MW polymerization unknown. | One homolog, IRX10 with similar activity. Two related GT43 enzymes (IRX14 and IRX14-L) are putative xylan backbone transferases. Activity not confirmed. | Zeng et al., |
| GUX | D-GlcA | α-1,2-GlcA side chain initiation on xylan backbone | 8 | Xylan backbone acceptors, DP 2–6. Xyl monosaccharide tested, no activity detected. | Single addition to DP 6 acceptor. Fifth Xylose from nonreducing end preferred (XXXXGX). Some product contains single addition on third Xylose from nonreducing end (XXGXGX). Strong preference for longer acceptors (DP ≥ 6). | Five-member family. Activity for GUX1, 2 and 4. GUX3 activity inconsistent from two independent publications: GUX3 and GUX5 may be noncatalytic. | Lee et al., |
| XAT1 | L-Ara | α-1,3-Ara side chain initiation on xylan backbone | 61 | Unknown: endogenous xylan acceptors in Arabidopsis. Gain-of-function evidence only. | Single addition to xylan acceptors of unknown size. Digested products reveal a pattern of DP 5 products containing an Ara side chain on the second Xyl from the nonreducing end (XAXX). | Wheat/rice gene. Arabinoxylans are low-abundance in Arabidopsis. Two putative GT61 homologs. | Anders et al., |
| XAX1 | D-Xyl | β-1,2-Xyl addition to α-1,3-linked Ara side chain (residues transferred by XAT1) on grass xylan | 61 | Unknown: endogenous xylan acceptors in | Unknown product size/structure: Most likely product detected by NMR is a xylan backbone oligosaccharide, DP 4, containing a Xyl-Ara side chain on the second Xyl from the nonreducing end. | Rice gene. Grass-specific clade not expected to be found in Arabidopsis. | Chiniquy et al., |
Gene annotations, abbreviations, and references are formatted as in .
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of xylan backbone synthesis is xylan:β-1,4-glucosyltransferase (xylan:β-1,4-GlcT) and the full linkage synthesized is Glcβ-1,4-Glc.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Pectin biosynthetic GTs of known function determined by heterologous expression.
| GAUT | D-GalA | α-1,4-GalA | 8 | HG backbone oligosaccharides, DP 3–15. | Elongation to HMW polymers >100 kDa. Large rate increase with acceptors DP ≥ 11. | 15-member family. Activity for GAUT1:GAUT7 complex, GAUT1, 4, and 11. High MW polymerization detected with GAUT1:GAUT7 complex only. | Sterling et al., |
| XGD1 | D-Xyl | β-1,3-Xyl side chain initiation on HG backbone | 47 | HG backbone oligosaccharide acceptor mix, DP 12–14. | Single addition to HG backbone. Unknown pattern of transfer or regiospecificity. | Activity for XGD1 only. Six additional homologs in GT47 subgroup C, no functions assigned. | Jensen et al., |
| RRT1 | L-Rha | α-1,4-Rha linkage on the non-reducing GalA of RG-I backbone acceptor: [-2)-α-Rha-(1,4)-α-GalA-(1-] | 106 | RG-1 repeating disaccharide acceptors of DP 5–14 containing GalA on the non-reducing end. | Single addition. GalAT activity needed for disaccharide elongation. Highest relative activity with DP 10 acceptor. DP 3–4 acceptors tested, no activity detected. | Four-member family. Activity for RRT1, 2, 3, and 4 detected. | Uehara et al., |
| GALS | D-Gal and L-Ara | β-1,4-Gal side branch elongation of galactans linked to RG-I backbone | 92 | AG oligosaccharides (β-1,4-Gal), DP 4–7. DP 1–3 acceptors tested, minimal, or no activity detected. | Elongation of DP 5 acceptor to DP ~ 11 detected by carbohydrate gel electrophoresis. High MW polymerization unknown. Acceptors of DP ≥ 5 preferred. Single addition of Arap prevents further elongation of chain. ~10-fold higher affinity for UDP-Gal over UDP-Ara | Three-member family. GalT activity for GALS1, 2, and 3. Lower activity/less transfers for GALS2 and 3. Ara | Liwanag et al., |
| RGXT | D-Xyl | α-1,3-Xyl addition to Fuc in RG-II side chain A | 77 | L-Fuc monosaccharide. | Single addition to synthesize Xyl-Fuc disaccharide. Full oligosaccharide acceptor containing RG-II backbone and side chain A residues not tested. | Four-member family. Activity for all RGXT1, 2, 3, and 4. | Egelund et al., |
Gene annotations, abbreviations, and references are formatted as in .
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of HG backbone synthesis is homogalacturonan:α-1,4-galacturonosyltransferase (HG:α-1,4-GalAT) and the full linkage synthesized is GalAα-1,4-GalA.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Arabinogalactan protein biosynthetic GTs of known function determined by heterologous expression.
| GALT | D-Gal | β-1,4-Gal backbone initiation on AGP hydroxyproline residue | 31 | Synthetic peptide acceptor consisting of 7 or 14 Ala-Hyp [AO] dipeptide repeats. Deglycosylated protein acceptor containing 51 [AO] repeats. | Single addition to initiate AG chain on AGP. Relatively higher activity with synthetic peptides than with deglycosylated protein acceptor. Unknown pattern of transfer or regiospecificity. | Five-member family. Activity for GALT2-6. GALT1 is non-cell wall related. | Basu et al., |
| HPGT | D-Gal | β-1,4-Gal backbone initiation on AGP hydroxyproline residue | 31 | Synthetic peptide acceptor consisting of repeats containing non-contiguous Hyp residues. | Single addition to initiate AG chain on AGP. Relatively higher activity with peptides containing more repeats. | Three-member family. Activity for HPGT1, 2, and 3. | Ogawa-Ohnishi and Matsubayashi, |
| At1g77810 | D-Gal | β-1,3-Gal | 31 | β-1,3-Gal disaccharide acceptor. | Single addition to disaccharide synthesizes DP3 products. Continued elongation of AG backbone unknown. | No identified homologs. | Qu et al., |
| GALT29A | D-Gal | β-1,6-Gal side branch elongation and initiation on β-1,3-Gal backbone | 29 | Heterogeneous AGP acceptor mix on a synthetic peptide expressed and glycosylated in | Elongation of β-1,3 (backbone) and β-1,6- (side branch) acceptors. Unknown length of elongation or specific acceptor preferences. | No identified homologs. | Dilokpimol et al., |
| GALT31A | D-Gal | β-1,6-Gal side branch elongation | 31 | Heterogeneous AGP acceptor mix on a synthetic peptide expressed and glycosylated in | Elongation of β-1,6- (side branch) acceptors. Elongation of DP 3, but not DP 2, acceptors. Unknown length of elongation. | No identified homologs. | Geshi et al., |
| GlcAT14 | D-GlcA | β-1,6-GlcA side chain addition to β-1,3-Gal AG backbone and β-1,6-Gal AG side branches | 14 | Heterogeneous AGP acceptor mix on a synthetic peptide expressed and glycosylated in | Single addition to both β-1,6 (side branch) and β-1,3 (backbone) linkages within AGP polysaccharides. Unknown pattern of elongation. No activity detected with β-1,3-Gal oligosaccharides DP <5. | Three-member family. Activity for GlcAT14A, B, and C. | Knoch et al., |
| FUT4/FUT6 | L-Fuc | α-1,2-Fuc addition to various α-1,3-Ara linked to the β-1,6-Gal AG side branches | 37 | Non-fucosylated AGP polysaccharide extracted by Yariv reagent from tobacco BY2 cells. | Single addition to L-Ara side chain residues in both β-1,6 (side chain) linkages within AGP polysaccharides. Unknown pattern of elongation. | 10-member FUT family. FUT4 and FUT6 are AGP-specific, redundancy unknown. Two known Fuc acceptor sites in AGP. | Wu et al., |
Gene annotations, abbreviations, and references are formatted as in .
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of AGP backbone synthesis is β-1,3-galactosyltransferase (β-1,3-GalT) and the full linkage synthesized is Galβ-1,3-Gal.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Mixed-linkage glucan biosynthetic GTs of known function determined by heterologous expression.
| CSLF | D-Glc | (1,3;1,4)-β-Glc | 2 | Unknown: endogenous acceptors or | Unknown length of MLG backbone products. Varying DP3:DP4 ratios from barley (~1.6:1) and sorghum (1.0:1) CSLF6 orthologs. | MLG not detected in Arabidopsis. 10-member family in | Burton et al., |
| CSLH | D-Glc | (1,3;1,4)-β-Glc | 2 | Unknown: endogenous acceptors or | Unknown length of MLG backbone products. DP3:DP4 ratio ~3.6 from barley enzyme. | MLG not detected in Arabidopsis. Barley enzyme. | Doblin et al., |
| CSLJ | D-Glc | (1,3;1,4)-β-Glc | 2 | Unknown: endogenous acceptors or | Unknown length of MLG backbone products. DP3:DP4 ratio ~1.3 from barley enzyme. | MLG not detected in Arabidopsis. Barley enzyme. | Little et al., |
Gene annotations, abbreviations, and references are formatted as in .
Trans. is an abbreviation for transferred.
Activities are listed as simplified descriptions of the monosaccharide transferred. Side chain activities are listed as “initiation” for the first residue attached to the polysaccharide backbone or “addition” for subsequent residues added to an extended side chain. Full activity names include the designation “transferase” and the polysaccharide acceptor, where applicable. As an example, the full activity name of MLG backbone synthesis is β-(1,3;1,4)-glucosyltransferase [β-(1,3;1,4)-GlcT] and the full linkage synthesized is Glcβ-(1,3;1,4)-Glc.
Products synthesized are listed in italics by common names used in the literature, where applicable.
CAZy GT family.
Only acceptors with confirmed activity in the references cited are listed. Other acceptors that did not yield activity may have been tested and are not included.
Chain length of plant cell wall polysaccharides synthesized in vivo and in vitro.
| Xyloglucan (XG) | 9–900 Storage XG: >1000 | 28–2800 | SEC | Park and Cosgrove, | Unknown: assumed to be long due to high ratio of 4-linked glucose to terminal-glucose. | Linkage analysis | Cocuron et al., | |
| 90 | 280 | AFM | Park and Cosgrove, | |||||
| Xylan | Glucuronoxylan: ~12 | 93 | NMR | Pena et al., | ~3–5 | ~21–34 | MALDI-MS | Urbanowicz et al., |
| Glucuronoxylan: 5–130 Arabinoxylan and complex heteroxylan: 64–380 | N/A | SEC | Ebringerová et al., | |||||
| Mannan/Glucomannan (GM) | Woody: 1–64 GalMan: 960–1260 | ~10–400 ~6000–7800 | SEC | Ebringerová et al., | Pure mannan: 175 >2000 GM: 64–560, peak 130 | ~1000 >6000 ~800 | SEC | Dhugga et al., |
| Konjac GM: 1020 250 | ~6000 ~1500 | SEC-MALS | Makabe et al., | |||||
| ~1–4 | 11–20 | MALDI-MS | Lundqvist et al., | |||||
| Mixed-linkage glucan (MLG) | >250 | >1500 | SEC | Carpita and Mccann, | Unknown: products analyzed after lichenase digestion. Long-chain products not measured. | N/A | Dimitroff et al., | |
| Homogalacturonan (HG) | ~14–20 | 81–117 | SEC | Yapo et al., | >100 | >500 | SEC | Amos et al., |
| ~60 | ~320 | AFM | Round et al., | |||||
| Embedded within RG-I domains: ~1–2 | 4–10 | MS, NMR | Nakamura et al., | |||||
| Rhamnogalacturonan-I (RG-I) | 6 (12% of 50 kDa branched polymer) Full polymer: 23–900 | ~20 N/A | SEC | Yapo, | Unknown: due to disaccharide backbone, only single addition to acceptor can be detected. | Anion exchange chromatography and tandem MS | Takenaka et al., | |
| Debranched: 15 Full polymer: 56 | ~40 N/A | SEC-MALS | Yapo et al., | |||||
| Arabinogalactan from RG-I (AG) | Galactans: ~1–8 Arabinans: ~1–27 | 2–50 2–200 | SEC | Yapo, | Galactans: ~1–2 | 11 | TLC and PACE | Laursen et al., |
| Arabinogalactan protein (AGP) | 5–25 | 30–120 | SEC | Ellis et al., | Unknown: product size not analyzed. | N/A | Geshi et al., | |
Chain length values (kDa and DP) are either stated directly in references, inferred from reported data, or are a range of figures compiled within reviews. If only the kDa or DP value was reported, the other value was estimated from the molecular weight of component monosaccharides. In some cases, the chain length in DP cannot be estimated due to large amounts of heterogeneity and side-chain branching, indicated by N/A. Use of a tilde (~) indicates estimated values and use of a greater-than sign (>) indicates that high molecular weight polymers that elute near the void volume of a size exclusion column are unable to be precisely measured and the reported size is compared to a dextran standard. SEC, size exclusion chromatography; AFM, atomic force microscopy; MALS, multiangle light scattering; MS, mass spectrometry; MALDI, Matrix-assisted laser desorption/ionization; TLC, thin-layer chromatography; PACE, polysaccharide analysis using carbohydrate gel electrophoresis.
Figure 2Polysaccharide chain elongation patterns for processive, distributive, and two-phase distributive glycosyltransfer. Glycosyltransferases synthesize polysaccharides by different mechanisms that result in characteristic product profiles over the progress of an elongation reaction. The hypothetical product profiles shown correspond to the elongation of a short-chain acceptor (left) into longer-chain products (right). Three panels are shown for each proposed mechanism corresponding to the early, middle, and late stages of reaction progress. Product profiles are representative of several methods that are used to obtain chain length information, including HPLC, MALDI-MS, and polyacrylamide gel electrophoresis. In processive elongation, formation of an enzyme-substrate catalytic complex that is maintained through many rounds of monosaccharide transfer leads to a bimodal distribution of low and high MW products (Levengood et al., 2011; Raga-Carbajal et al., 2016). In distributive elongation, dissociation of the acceptor substrate following each round of addition and the lack of acceptor length bias leads to a Poisson distribution of products over time (Keys et al., 2014; Urbanowicz et al., 2014). A two-phase distributive mechanism accumulates short-chain products during the early phase of the reaction followed by rapid elongation of high MW polysaccharides resulting from large increases in catalytic efficiency for acceptors with chain lengths longer than a “Critical DP” (Vionnet and Vann, 2007; Amos et al., 2018). The product distribution of a two-phase distributive mechanism can resemble the bimodal distribution observed by processive glycosyltransferases. Chain length analysis may be suggestive of a particular elongation mechanism, but processivity cannot necessarily be inferred without direct evidence, such as the multi-TM translocation pore found in crystal structures of the BcsA:BscB cellulose synthase complex and proposed for other GT2-family structures (Morgan et al., 2013; Bi et al., 2015).
Enzymatic rates and reaction kinetics of plant cell wall polysaccharides synthesized in vitro.
| Xys1 | Xylohexaose Acceptor | UDP-Xyl Donor | 800 | 0–4000 | 1.17 | 0.39 | 0.0004 | 15.8 pmol | 120 | Urbanowicz et al., |
| GAUT1: GAUT7 | UDP-GalA Donor | HG mix DP 7–23 Acceptor | 5–2000 | 100 | 151 ± 10.6 | 165.4 ± 3.4 | 0.92 ± 0.02 | 3 pmol | 5 | Amos et al., |
| HG DP 7–23 mix Acceptor | UDP-GalA Donor | 1000 | 0.01–50 | 0.8 ± 0.1 | 359.0 ± 10.2 | 1.99 ± 0.06 | 3 pmol | 5 | ||
| HG DP11 Acceptor | UDP-GalA Donor | 1000 | 0.01–100 | 1.4 ± 0.2 | 705.0 ± 53.9 | 3.92 ± 0.3 | 3 pmol | 5 | ||
| HG DP7 Acceptor | UDP-GalA Donor | 1000 | 0.01–100 | 10.0 ± 1.4 | 109.8 ± 3.7 | 0.61 ± 0.02 | 3 pmol | 30 | ||
| GalS1 | UDP-Xyl Donor | Galactopentaose Acceptor | 0–500 | 50 | 142 ± 12 | 656 ± 42 | N/A | 25 μg microsomal protein | 15 | Laursen et al., |
| UDP-Ara | Galactopentaose Acceptor | 0–3000 | 50 | 1057 ± 222 | 454 ± 51 | N/A | 25 μg microsomal protein | 60 | ||
| XXT1 | UDP-Xyl Donor | Cellohexaose Acceptor | 0–4000 | 1000 | 490 ± 40 | 509.25 ± 14.25 | 0.11 ± 0.003 | 75 pmol | 30 | Culbertson et al., |
| XXT2 | UDP-Xyl Donor | Cellohexaose Acceptor | 0–4000 | 1000 | 640 ± 90 | 373.5 ± 17.25 | 0.083 ± 0.004 | 75 pmol | 30 | Culbertson et al., |
| XXT5 | UDP-Xyl Donor | Cellohexaose Acceptor | 0–4000 | 1000 | 4800 ± 330 | 166.5 ± 74.75 | 0.01 ± 0.004 | 287.5 pmol | 60 | Culbertson et al., |
| FUT1 | GDP-Fuc Donor | XXLG Oligosaccharide Acceptor | 0–400 | 750 | 25.32 ± 4.2 | 14.1 ± 0.2 | 0.063 ± 0.0008 | 3.7 pmol | 20 | Urbanowicz et al., |
| XXLG Oligosaccharide Acceptor | GDP-Fuc Donor | 200 | 0–800 | 201 ± 12.0 | N/A | N/A | 3.7 pmol | 20 | ||
| GUX1 | UDP-GlcA Donor | Xylohexaose Acceptor | 10–3000 | 400 | 165 ± 25 | N/A (arbitrary units) | N/A | 100 μg microsomal protein | 60 | Rennie et al., |
All units listed in this table are standardized from reported data.
K.
Rates are converted to pmol/min per enzyme amount listed in table from reported data.
k.
Enzyme amounts are converted into pmol if reported in ng using the predicted molecular weights of full-length or truncated proteins. Microsomal protein cannot be used to calculate kcat values due to an unknown concentration of target protein within microsomes. Calculations used to standardize reported values are explained with the original values from each reference in .
Chain length values (kDa and DP) are either stated directly in references, inferred from reported data, or are a range of figures compiled within reviews. If only the kDa or DP value was reported, the other value was estimated from the molecular weight of component monosaccharides. In some cases, the chain length in DP cannot be estimated due to large amounts of heterogeneity and side-chain branching, indicated by N/A. Use of a tilde (~) indicates estimated values and use of a greater-than sign (>) indicates that high molecular weight polymers that elute near the void volume of a size exclusion column are unable to be precisely measured and the reported size is compared to a dextran standard. SEC, size exclusion chromatography; AFM, atomic force microscopy; MALS, multiangle light scattering; MS, mass spectrometry; MALDI, Matrix-assisted laser desorption/ionization; TLC, thin-layer chromatography; PACE, polysaccharide analysis using carbohydrate gel electrophoresis.